Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Taysha Gene Therapies
TSHA
$1.9B
| $1.52M | ﹤0.01% |
+878,448
| New | +$1.82M |
|
2227
Invesco S&P MidCap Momentum ETF
XMMO
$7.71B
| $1.52M | ﹤0.01% |
12,300
+5,628
| +84% | +$714K |
|
|
CIM
2228
Chimera Investment
CIM
$988M
| $1.52M | ﹤0.01% |
108,453
-32,900
| -23% | -$493K |
|
2229
Orion Group Holdings
ORN
$402M
| $1.52M | ﹤0.01% |
206,890
-199,727
| -49% | -$1.44M |
|
2230
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $1.51M | ﹤0.01% |
15,100
-7,800
| -34% | -$773K |
|
2231
Vera Therapeutics
VERA
$2.28B
| $1.51M | ﹤0.01% |
+35,700
| New | +$1.58M |
|
|
FSFG
2232
DELISTED
First Savings Financial Group
FSFG
| $1.51M | ﹤0.01% |
56,800
+27,100
| +91% | +$732K |
|
2233
Nuvation Bio
NUVB
$2.18B
| $1.51M | ﹤0.01% |
566,800
-462,200
| -45% | -$1.19M |
|
2234
Dana Inc
DAN
$3.26B
| $1.51M | ﹤0.01% |
130,400
-55,800
| -30% | -$580K |
|
2235
Harvard Bioscience
HBIO
$30.3M
| $1.5M | ﹤0.01% |
70,978
-1,430
| -2% | -$32.8K |
|
2236
Pulmonx
LUNG
$104M
| $1.5M | ﹤0.01% |
220,510
+61,500
| +39% | +$405K |
|
2237
Cardlytics
CDLX
$24.9M
| $1.5M | ﹤0.01% |
40,341
-753
| -2% | -$28.8K |
|
2238
Assembly Biosciences
ASMB
$653M
| $1.49M | ﹤0.01% |
94,711
+29,087
| +44% | +$468K |
|
2239
Mission Produce
AVO
$1.15B
| $1.49M | ﹤0.01% |
103,800
+70,500
| +212% | +$911K |
|
2240
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $1.49M | ﹤0.01% |
57,000
-48,400
| -46% | -$1.32M |
|
2241
Nerdy
NRDY
$90.4M
| $1.49M | ﹤0.01% |
919,441
-999,250
| -52% | -$1.24M |
|
2242
Urban Edge Properties
UE
$2.76B
| $1.49M | ﹤0.01% |
69,275
-25
| -0% | -$556 |
|
2243
Triple Flag Precious Metals
TFPM
$6.48B
| $1.49M | ﹤0.01% |
98,900
+8,200
| +9% | +$136K |
|
2244
DocGo
DCGO
$65.9M
| $1.49M | ﹤0.01% |
350,600
+299,300
| +583% | +$1.15M |
|
2245
Peoples Financial Services
PFIS
$714M
| $1.49M | ﹤0.01% |
29,027
-1,400
| -5% | -$71.2K |
|
|
HTLF
2246
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.48M | ﹤0.01% |
+24,200
| New | +$1.51M |
|
2247
FB Financial Corp
FBK
$3.09B
| $1.48M | ﹤0.01% |
+28,762
| New | +$1.5M |
|
|
ORGN
2248
DELISTED
Origin Materials
ORGN
| $1.48M | ﹤0.01% |
38,440
+25,357
| +194% | +$963K |
|
|
SEVN
2249
Seven Hills Realty Trust
SEVN
$176M
| $1.48M | ﹤0.01% |
112,834
-28,000
| -20% | -$373K |
|
|
SNCY
2250
DELISTED
Sun Country Airlines
SNCY
| $1.48M | ﹤0.01% |
+101,200
| New | +$1.37M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.